Brief: PMV Pharmaceuticals Inc Reports Second Quarter 2022 Financial Results
Aug 9 (Reuters) - PMV Pharmaceuticals Inc PMVP.O :
* PMV PHARMACEUTICALS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND CORPORATE HIGHLIGHTS
* AS OF JUNE 30, 2022, PMV PHARMA HAD $277.4 MILLION IN
CASH, CASH
EQUIVALENTS, AND MARKETABLE SECURITIES
* QTRLY NET LOSS PER SHARE -- BASIC AND DILUTED $0.38
* Q2 EARNINGS PER SHARE VIEW $-0.41 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6zWXHN
Further company coverage: PMVP.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Pmv Pharmaceuticals
See all newsAustralia's Premier Investments jumps as Citi backs in-line earnings
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple
U.S. STOCKS ON THE MOVE-GoPro, TXNM Energy, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Fervo Energy, Myriad Genetics, Emergent BioSolutions
U.S. STOCKS ON THE MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics